Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
Nicola Tumino, Anna Laura Di Pace, Francesca Besi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Natural killer cells in antitumour adoptive cell immunotherapy
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 442
Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhӓuser, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3778-3778
Open Access | Times Cited: 108
Tumor Abnormality-Oriented Nanomedicine Design
Quan Zhou, Jiajia Xiang, Nasha Qiu, et al.
Chemical Reviews (2023) Vol. 123, Iss. 18, pp. 10920-10989
Closed Access | Times Cited: 72
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 51
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects
Enrico Munari, Francesca Romana Mariotti, Linda Quatrini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5123-5123
Open Access | Times Cited: 85
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
Nicola Tumino, Gerrit Weber, Francesca Besi, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
Shweta Joshi, Andrew B. Sharabi
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108114-108114
Open Access | Times Cited: 47
Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
Alain E. Andrea, Andrada Chiron, Sarah Mallah, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
Shifen Wang, Xingyun Zhao, Siwen Wu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
Nicola Tumino, Francesca Besi, Stefania Martini, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
Shunjie Yu, Xiaotong Ren, Lijuan Li
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, et al.
Environmental Research (2023) Vol. 235, pp. 116573-116573
Closed Access | Times Cited: 16
Cancer-associated fibroblast-derived exosomes in cancer progression: a focus on hepatocellular carcinoma
Chou‐Yi Hsu, Abdulrahman T. Ahmed, Safia Obaidur Rab, et al.
Experimental Cell Research (2025), pp. 114424-114424
Closed Access
The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
Chengyuan Li, Yucheng Xue, Eloy Yinwang, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy
Adeleye O. Adeshakin, Funmilayo O. Adeshakin, Dehong Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche
Jesse Kreger, Evanthia T. Roussos Torres, Adam L. MacLean
Cancer Immunology Research (2023) Vol. 11, Iss. 5, pp. 614-628
Open Access | Times Cited: 12
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
Sunčica Kapor, Juan F. Santibáñez
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2788-2788
Open Access | Times Cited: 27
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells
Nicola Tumino, Piera Filomena Fiore, Andrea Pelosi, et al.
Seminars in Immunology (2022) Vol. 61-64, pp. 101668-101668
Open Access | Times Cited: 19
Dual roles of myeloid-derived suppressor cells in various diseases: a review
Mahesh R. Nepal, S. P. Shah, Kyu‐Tae Kang
Archives of Pharmacal Research (2024) Vol. 47, Iss. 7, pp. 597-616
Closed Access | Times Cited: 3
Natural killer cells act as an extrinsic barrier for in vivo reprogramming
Elena Melendez, Dafni Chondronasiou, Lluc Mosteiro, et al.
Development (2022) Vol. 149, Iss. 8
Open Access | Times Cited: 15
Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort
Svetlana Glushkova, Larisa Shelikhova, K. A. Voronin, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 435.e1-435.e12
Closed Access | Times Cited: 2
Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities
Harshita Tiwari, Swati Singh, Sonal Sharma, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment
Eleonora Russo, Mattia Laffranchi, Luana Tomaipitinca, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target
Ehsan Nourbakhsh, Ali Mohammadi, Mohammad Salemizadeh Parizi, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 5, pp. 1307-1315
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top